Ryali Sriram

CIK 0001762893

Chief Financial Officer

Filings

Latest Feb 20, 2026

Issuers covered

Showing

8 of 8

Page 1

Track record

2 of 3 open-market trades scored (67% price coverage) - 1 issuer without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

Horizon	Trades	Win rate	Avg	Median	Best	Worst
30 days	2	50%	+3.2%	+3.2%	+19.2%	-12.7%
90 days	2	50%	-4.3%	-4.3%	+27.9%	-36.4%
180 days	2	100%	+91.3%	+91.3%	+111.6%	+70.9%
365 days	2	100%	+31.4%	+31.4%	+52.3%	+10.4%

Issuers

Companies where Ryali Sriram has filed

Ticker	Issuer	Filings	Last filed
CDXS	Codexis, Inc.	3	Jan 2, 2024
CRBU	Caribou Biosciences, Inc.	3	Feb 20, 2026
EIGR	Eiger Biopharmaceuticals, Inc.	2	Mar 14, 2022

All filings

8 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Feb 20, 2026	CRBUCaribou Biosciences, Inc.	AGrant	55,000	$0.00	$0
Jan 30, 2025	CRBUCaribou Biosciences, Inc.	PPurchase	17,360	$1.42	$24,651
Jan 10, 2025	CRBUCaribou Biosciences, Inc.	Holdings only	-	-	-
Jan 2, 2024	CDXSCodexis, Inc.	AGrant	52,350	$0.00	$0
Sep 12, 2023	CDXSCodexis, Inc.	PPurchase	11,650	$1.7044	$19,856
Feb 14, 2023	CDXSCodexis, Inc.	AGrant	111,791	$0.00	$0
Mar 14, 2022	EIGREiger Biopharmaceuticals, Inc.	SSale	2,266	$5.5973	$12,683
Mar 11, 2022	EIGREiger Biopharmaceuticals, Inc.	AGrant	24,000	$0.00	$0

Showing 1-8 of 8

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.

Filed		Top transaction	Shares	Price	Value